Related Experiment Video
Updated: Mar 19, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
H2 S inhibits apo(a) expression and secretion through PKCα/FXR and Akt/HNF4α pathways in HepG2 cells
Kai Qu1, Ya-Mi Liu1, Xing-Lan He1
1Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan, 421001, PR China.
Abstract:
Lipoprotein(a) [Lp(a)] is a strong genetic risk factor for coronary heart diseases. However, the metabolism of this protein remains poorly understood. Efficient and specific drugs that can decrease high plasma levels of Lp(a) have not been developed yet. Hydrogen sulfide (H2 S), a member of the gas transmitter family, performs important biological actions, including protection against cardiovascular diseases and maintenance of the lipid metabolism equilibrium in hepatocytes and adipocytes. In this study, we investigated the possible molecular mechanism of H2 S that influences apolipoprotein(a) [apo(a)] biosynthesis. We also determined the effects of H2 S on apo(a) expression and secretion in HepG2 cells as well as the underlying mechanisms. Results showed that H2 S significantly inhibited the expression and secretion levels of apo(a). These effects were attenuated by the PKCα inhibitor and FXR siRNA. H2 S also reduced HNF4α expression and enhanced FXR expression. The Akt inhibitor partially reversed H2 S-induced inhibition of apo(a) and HNF4α expression and apo(a) secretion. This study reveals that H2 S suppressed apo(a) expression and secretion via the PKCα-FXR and PI3K/Akt-HNF4α pathways.
Insights
Hydrogen sulfide (H2S) significantly reduces apolipoprotein(a) [apo(a)] expression and secretion. This gas transmitter impacts lipid metabolism via PKCα-FXR and PI3K/Akt-HNF4α pathways, offering potential cardiovascular disease therapeutic strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Science
Background:
- Lipoprotein(a) [Lp(a)] is a key genetic risk factor for coronary heart disease.
- Understanding Lp(a) metabolism and developing drugs to lower its plasma levels are critical unmet needs.
- Hydrogen sulfide (H2S) is recognized for its cardioprotective effects and role in lipid metabolism.
Purpose of the Study:
- To elucidate the molecular mechanisms by which H2S influences apolipoprotein(a) [apo(a)] biosynthesis.
- To determine the effects of H2S on apo(a) expression and secretion in HepG2 cells.
- To identify the signaling pathways involved in H2S-mediated regulation of apo(a).
Main Methods:
- Investigated H2S effects on apo(a) expression and secretion in HepG2 cells.
- Utilized PKCα inhibitor and FXR siRNA to probe signaling pathways.
- Assessed the impact of H2S on HNF4α and FXR expression.
- Employed Akt inhibitor to evaluate the PI3K/Akt pathway involvement.
Main Results:
- H2S significantly inhibited apo(a) expression and secretion in HepG2 cells.
- PKCα inhibition and FXR knockdown attenuated the effects of H2S on apo(a).
- H2S reduced HNF4α expression and increased FXR expression.
- Akt inhibition partially reversed H2S-induced inhibition of apo(a) and HNF4α expression and secretion.
Conclusions:
- H2S suppresses apo(a) biosynthesis and secretion through distinct molecular pathways.
- The PKCα-FXR pathway is implicated in H2S-mediated regulation of apo(a).
- The PI3K/Akt-HNF4α pathway also plays a role in H2S's inhibitory effects on apo(a).
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Regulation of Nuclear Protein Sorting
Inhibitors of Viral Protein Synthesis

